Axios Alerts: Medicare may cover controversial Alzheimer's drug with restrictions

Alerts   Axios    Medicare proposes covering Aduhelm, with restrictions Why it matters: Patients would have to be enrolled in a randomized clinical study.   Download the Axios App Follow Axios on Social Media Contact Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201   You received this email because you signed up for news alerts from Axios. Change your preferences or unsubscribe here.